GlassScriptPhysician profile
Asim J Khattak
NPI 1578520730
$714.48
in general payments reported to CMS, 2019-2025
10 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $111 · 2024: $196 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.08 | 2022-2025 | Jardiance |
| Exact Sciences Corporation | $111.72 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $96.32 | 2025 | Airsupra, Breztri |
| Novo Nordisk INC | $76.93 | 2024-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $75.06 | 2022-2025 | |
| Abbott Laboratories | $52.17 | 2023-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $49.72 | 2022-2024 | Shingrix, Arexvy |
| Dynavax Technologies Corporation | $24.20 | 2025 | Heplisav-B |
| Phadia US INC. | $19.61 | 2022 | |
| Amarin Pharma, INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Khattak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.